BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis

FREDERICK, MD. January 5, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization¹ by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, … Continue Reading

BioElectronics Announces Oxford University Sponsored Study

ActiPatch® Therapy for Chronic Low Back Pain FREDERICK, MD. Dec 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that Oxford University is sponsoring a clinical trial on chronic lower back pain using ActiPatch® Therapy. Chronic low back pain is a major health problem and has significant … Continue Reading

BioElectronics’ ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada

FREDERICK, MD. December 7, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase stores. Chris Russell, President, Chris-Kelly, LLC, stated, “We are excited to have a retail partner like Showcase only eight … Continue Reading

BioElectronics Chairman of the Board Interview

A New Audio Interview With Rick Staelin, Chairman of the Board for BioElectronics Corporation, is Now at SmallCapVoice.com AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now … Continue Reading

BioElectronics’ ActiPatch® Pain Therapy Expands Into Costco Canada

FREDERICK, MD. November 19, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco’s online store, http://www.costco.ca/CatalogSearch?storeId=10302&catalogId=11201&langId=-24&refine=&keyword=actipatch. Chris Russell, President, Chris-Kelly, LLC, the Canadian distributor, stated, “This product placement in … Continue Reading

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

FREDERICK, MD. November 9, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world’s largest international health and beauty … Continue Reading

UpTick News Wire Radio Show Will Interview BioElectronics’ CEO Andrew Whelan

Topics will Include UK Market Expansion and US FDA Status FREDERICK, MD. November 4, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management announced that Andrew J. Whelan, President will be interviewed by Stu Taylor on his program “On Business“ at 9am EST on Thursday, November 5th. To … Continue Reading

BioElectronics’ UK ActiPatch® Pain Therapy Market Expands Into 1,077 Lloyds Pharmacies and 60 Gordons Chemist

FREDERICK, MD. October 20, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received initial orders for its ActiPatch® Musculoskeletal Pain Relief products for 1,077 Lloyd’s pharmacies, the second largest chain in the UK, and Gordons Chemist. ActiPatch will be on promotion in … Continue Reading

BioElectronics Applauds the FDA’s Reclassification of Nonthermal Shortwave Therapy Devices

FREDERICK, MD. October 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management endorsed the U.S. Food and Drug Administration’s final rule 890.5290 on nonthermal pulsed shortwave devices published today in the Federal Register. “I am pleased the agency has completed this step in streamlining the regulatory requirements … Continue Reading